London, June 22, 2020 (GLOBE NEWSWIRE) -- Susceptibility testing is used in the determination of the antimicrobials inhibiting the growth of the bacteria or fungi causing a specific infection. The aim of antimicrobial susceptibility testing is to predict the in vivo success or failure of antibiotic therapy. Tests performed measure the growth response of an isolated organism to a particular drug or drugs. The results of this test help a healthcare practitioner to determine the most effective drug for treatment of infections. The global burden of infectious diseases is resulting into growing need for susceptibility testing and scientists are striving to develop broad spectrum antibiotics and check microbial susceptibility against them.
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5062
Moreover, due to the inappropriate use of antimicrobial medicines, there is emergence of multidrug resistance and resistance developed by various pathogens against the drugs targeted against them is considered as a threat to public health. For instance, World Health Organization (WHO) states that in 2017, 6,00,000 cases were reported for resistance to rifampicin, which is the most effective first-line antibiotic for tuberculosis; of these cases, approximately 82% were resistant to multiple treatment options. Thus, the increasing number of pathogenic bacteria acquiring multidrug resistance and new forms of resistance is persuading clinicians to perform antimicrobial susceptibility testing (AST) on priority. With respect to the clinical microbiology laboratories, their responsibility is associated with the treatment of the disease including the isolation and identification of the causative pathogen and performing antibiotic susceptibility testing (ASTs).
Hence, governments across the globe are heavily focusing on increasing the awareness about the treatment of infections caused by pathogens and are consistently undertaking initiatives to promote antimicrobial susceptibility testing prior to antibiotic treatment. In 2018, the U.K. government launched a five-year national action plan detailing the contribution of the U.K. in controlling the growing global problem of antimicrobial resistance. Also, the prime minister of India launched ‘TB Free India’ campaign to end tuberculosis (TB) in India by 2025 in March 2018. These initiatives help in to educate decision makers, regulatory agencies, and other end-users regarding the prevention of infections, thereby promoting AST.
The antimicrobial susceptibility testing market is expected to grow at a CAGR of 6.1% from 2019 to 2027 to reach $5.09 billion by 2027. The growth in this market is majorly driven by factors such as rising prevalence of infectious diseases, increased funding and government initiatives, emergence of multidrug resistance, and technological advancements towards the development of rapid AST methods. However, stringent government regulations associated with the AST products hinders the growth of this market.
The global antimicrobial susceptibility testing market studied in this report is segmented on the basis of method (disk diffusion, dilution, rapid automated AST, others), products (manual AST products, automated AST products, consumables), application (clinical diagnosis, drug discovery & development, others), end users (diagnostic laboratories and hospitals, pharmaceutical and biotechnology companies, research and academic institutes), and geography.
On the basis of product type, manual AST products accounted for the largest share of the overall antimicrobial susceptibility testing market in 2019. The major share of this segment is primarily attributed to the low cost of the manual AST products and requirement of simple handling procedures for these products.
On the basis of method, the disk diffusion segment commanded the largest share of the overall antimicrobial susceptibility testing market in 2019. The major share of this segment is attributed to the simplicity of the test, low cost, and flexibility in selection of disks.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5062
On the basis of application, the clinical diagnosis segment accounted for the largest share of the overall antimicrobial susceptibility testing market in 2019. The major share of this segment is attributed to rising burden of antimicrobial resistance and growing awareness about the use of antimicrobial susceptibility testing methods.
On the basis of end user, diagnostic laboratories & hospitals accounted for the largest share of the overall antimicrobial susceptibility testing market in 2019. The major share of this segment is attributed to the availability of the well-equipped facility and trained/skilled technicians and rise in hospital-acquired infections.
Geographically, the global antimicrobial susceptibility testing market is segmented into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa with a further analysis of the major countries in these regions. North America commanded the largest share of the global antimicrobial susceptibility testing market in 2019, followed by Europe and Asia-Pacific region. The major share of this region is mainly attributed to the better adoption of technologically advanced susceptibility testing methods and continuous research for new drugs using ASTs. On the other hand, Asia-Pacific region is projected to grow at the highest CAGR during the forecast period, owing to growing number of infectious diseases especially in China, increasing public health awareness, and self-medication or the increasing use of antibiotics without prescription within the region.
Some of the key players operating in the global antimicrobial susceptibility testing market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China) among others.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/antimicrobial-susceptibility-testing-market-5062/
Scope of the Report:
Antimicrobial Susceptibility Testing Market, by Method
- Disk Diffusion
- Automated AST
- Dilution
- Other Methods
(Other methods includes Etest & Genotypic Methods)
Antimicrobial Susceptibility Testing Market, by Products
- Manual Antimicrobial Susceptibility Testing Products
- Susceptibility Testing Disks
- MIC Strips
- Susceptibility Plates
- Automated Laboratory Instruments
- Consumables
Antimicrobial Susceptibility Testing Market, by Application
- Clinical Diagnostics
- Drug Discovery and Development
- Other Applications
(Other applications includes veterinary research, epidemiology & environmental monitoring.)
Antimicrobial Susceptibility Testing Market, by End-user
- Diagnostic Laboratories and Hospitals
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutes
Antimicrobial Susceptibility Testing Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5062
Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research.php
Related Reports:
Infection Control Market by Product [Sterilization (Steam, Radiation, Sterilant, Indicators), Disinfection (Washer, UV Disinfection, Disinfectants), Endoscope Reprocessing, Protective Barriers], and End User - Global Forecast to 2027
https://www.meticulousresearch.com/product/infection-control-market-5058/
In-Vitro Toxicology/Toxicity Testing Market by Product and Service, Technology (Cell Culture, OMICS), Method (Cell-based Assays, In-Silico), End-point (ADME, Genotoxicity, Organ Toxicity, Dermal Toxicity), End-user, and Geography – Global Forecast to 2025
https://www.meticulousresearch.com/product/in-vitro-toxicology-toxicity-testing-market-5047/
Research Antibodies and Reagents Market by Product (Reagent [Sample Preparation (Media, Probe, Buffer), Antibody Production Reagent], Antibody [Type, Source, Research Area]), Technology (Western Blot, ELISA), Application, End User - Global Forecast to 2025
https://www.meticulousresearch.com/product/research-antibodies-reagents-market-5055/
COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025
Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027
https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976/
Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, Research Institutes)–Global Forecast to 2027
https://www.meticulousresearch.com/product/influenza-diagnostics-market-5099/
About Meticulous Research®
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.